NCT00784277: A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease |
|
|
| Completed | 3 | 597 | US | oxycodone CR, oxycodone IR, Tapentadol ER (CG5503), Tapentadol IR (CG5503), placebo | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Grünenthal GmbH | Joint Diseases, Arthritis, Osteoarthritis | 07/09 | 07/09 | | |
